| Form
| Dosage
| Status
| Therapeutic Equivalence
| Active Ingred
| Ref.
| Sponsor
| Document
|
| INJECTABLE; INJECTION
| 3%
| Prescription
| AP (Reference Drug)
| MEPIVACAINE HYDROCHLORIDE
| Mepivacaine
| EASTMAN KODAK
| 012125
|
| INJECTABLE; INJECTION
| 1%
| Prescription
| AP (Reference Drug)
| MEPIVACAINE HYDROCHLORIDE
| Mepivacaine
| HOSPIRA
| 012250
2005-10-20 Letter
2005-09-30 Label |
| INJECTABLE; INJECTION
| 1.5%
| Prescription
| AP (Reference Drug)
| MEPIVACAINE HYDROCHLORIDE
| Mepivacaine
| HOSPIRA
| " |
| INJECTABLE; INJECTION
| 2%
| Prescription
| AP (Reference Drug)
| MEPIVACAINE HYDROCHLORIDE
| Mepivacaine
| HOSPIRA
| " |
| Role code
| Indications
| Reaction
| # Reports
|
| PS
| LOCAL ANAESTHESIA
| CIRCULATORY COLLAPSE
| 1
|
| PS
| LOCAL ANAESTHESIA
| LARYNGEAL OEDEMA
| 1
|
| PS
| LOCAL ANAESTHESIA
| OVERDOSE
| 1
|
| C
| ANALGESIC EFFECT
| ACCIDENTAL EXPOSURE
| 2
|
| C
| ANALGESIC EFFECT
| CONTUSION
| 1
|
| C
| ANALGESIC EFFECT
| DIZZINESS
| 2
|
| C
| ANALGESIC EFFECT
| GASTROENTERITIS VIRAL
| 2
|
| C
| ANALGESIC EFFECT
| PHARYNGOLARYNGEAL PAIN
| 2
|
| C
| ANALGESIC EFFECT
| SPINAL COMPRESSION FRACTURE
| 1
|
| C
| ANALGESIC EFFECT
| VOMITING
| 2
|